SLS · SELLAS Life Sciences Group, Inc.
$15.21
+1.48 (+10.78%)
At close · Aug 27
Going-concern doubt
— cleared Aug 11, 2026
The latest filing states the doubt was alleviated.
“In accordance with Accounting Standards Codification ("ASC") 205-40, Presentation of Financial Statements - Going Concern, the Company evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about its ability to continue as a going concern within one year after the consolidated financial statements are issued. The Company expects its cash and cash equivalents will be sufficient to fund its current planned operations for at least the next twelve months from the date of issuance of these consolidated financial statements”View the 10-Q filed Aug 11, 2026
Market Cap
$2.77B
Shares
201.95M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-08-11 | — | |
| 10-Q | 2026-08-11 | 2026-06-30 | |
| 8-K | 2026-07-27 | 2026-07-24 | |
| 8-K | 2026-06-25 | 2026-06-24 | |
| 8-K | 2026-06-18 | 2026-06-16 | |
| 8-K | 2026-06-02 | — | |
| 8-K | 2026-05-12 | — | |
| 10-Q | 2026-05-12 | 2026-03-31 | |
| DEF 14A | 2026-04-23 | 2026-06-16 | |
| 8-K | 2026-03-19 | — | |
| 10-K | 2026-03-19 | 2025-12-31 | |
| 8-K | 2026-03-11 | — | |
| 8-K | 2026-01-08 | 2026-01-07 | |
| 10-Q | 2025-11-12 | 2025-09-30 | |
| 8-K | 2025-11-12 | — | |
| 8-K | 2025-10-27 | 2025-10-24 | |
| 8-K | 2025-10-03 | 2025-10-01 | |
| 8-K | 2025-09-11 | 2025-09-10 | |
| 10-Q | 2025-08-12 | 2025-06-30 | |
| 8-K | 2025-08-12 | — | |
| 8-K | 2025-06-18 | 2025-06-17 | |
| 8-K | 2025-06-06 | 2025-06-03 | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| DEF 14A | 2025-04-23 | 2025-06-17 | |
| 8-K | 2025-03-20 | — | |
| 10-K | 2025-03-20 | 2024-12-31 | |
| 8-K | 2025-01-29 | 2025-01-28 | |
| 8-K | 2025-01-23 | — | |
| 8-K | 2025-01-16 | 2025-01-10 | |
| 8-K | 2024-12-10 | — | |
| 10-Q | 2024-11-13 | 2024-09-30 | |
| 8-K | 2024-11-13 | — | |
| 8-K | 2024-10-04 | 2024-10-03 | |
| 10-Q | 2024-08-13 | 2024-06-30 | |
| 8-K | 2024-08-13 | — | |
| 8-K | 2024-08-01 | 2024-07-30 | |
| 8-K | 2024-06-21 | 2024-06-20 | |
| 8-K | 2024-05-14 | — | |
| 10-Q | 2024-05-14 | 2024-03-31 | |
| DEF 14A | 2024-04-29 | 2024-06-20 | |
| 10-K | 2024-03-28 | 2023-12-31 | |
| 8-K | 2024-03-28 | — | |
| 8-K | 2024-03-28 | — | |
| 8-K | 2024-03-15 | — | |
| 8-K | 2024-03-11 | — | |
| 8-K | 2024-03-08 | 2024-03-06 | |
| 8-K | 2024-03-05 | — | |
| 8-K | 2024-02-16 | 2024-02-14 | |
| 8-K | 2024-01-08 | 2024-01-04 |
Showing 1–50 of 124 filings
Key facts
CIK
1390478
CUSIP
81642T209
13F (30d)
169 filings
167 filers
Visit website
Investor relations